European academy of andrology guidelines on Klinefelter Syndrome Endorsing Organization: European Society of Endocrinology. (6th October 2020)

• Record Type: Journal Article
• Authors: Zitzmann, Michael; Aksglaede, Lise; Corona, Giovanni; Isidori, Andrea M.; Juul, Anders; T'Sjoen, Guy; Kliesch, Sabine; D'Hauwers, Kathleen; Toppari, Jorma; Słowikowska‐Hilczer, Jolanta; Tüttelmann, Frank; Ferlin, Alberto
• Is Part Of: Andrology. Volume 9:Number 1(2021)
• Page Start: 145
• Page End: 167
• Publication Date: 2020-10-06
• Subjects: Andrology -- Periodicals; 616.65
• DOI: 10.1111/andr.12909
• Languages: English
• ISSNs: 2047-2919

Abstract

Abstract: Background: Knowledge about Klinefelter syndrome (KS) has increased substantially since its first description almost 80 years ago. A variety of treatment options concerning the spectrum of symptoms associated with KS exists, also regarding aspects beyond testicular dysfunction. Nevertheless, the diagnostic rate is still low in relation to prevalence and no international guidelines are available for KS. Objective: To create the first European Academy of Andrology (EAA) guidelines on KS. Methods: An expert group of academicians appointed by the EAA generated a consensus guideline according to the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) system. Results: Clinical features are highly variable among patients with KS, although common characteristics are severely attenuated spermatogenesis and Leydig cell impairment, resulting in azoospermia and hypergonadotropic hypogonadism. In addition, various manifestations of neurocognitive and psychosocial phenotypes have been described as well as an increased prevalence of adverse cardiovascular, metabolic and bone‐related conditions which might explain the increased morbidity/mortality in KS. Moreover, compared to the general male population, a higher prevalence of dental, coagulation and autoimmune disorders is likely to exist in patients with KS. Both genetic and epigenetic effects due to the supernumerary X chromosome as well as testosterone deficiency contribute to this pathological pattern. The majority of patients with KS is diagnosed during adulthood, but symptoms can already become obvious during infancy, childhood or adolescence. The paediatric and juvenile patients with KS require specific attention regarding their development and fertility. Conclusion: These guidelines provide recommendations and suggestions to care for patients with KS in various developmental stages ranging from childhood and adolescence to adulthood. This advice is based on recent research data and respective evaluations as well as validations performed by a group of experts.